A team of researchers at Dartmouth’s Geisel School of Medicine, led by Glyn Elwyn, MD, PhD, MSc, and Marie-Anne Durand, PhD, has received a $6.2 million funding award from the Patient-Centered Outcomes Research Institute (PCORI) to test approaches that may increase confidence in the COVID-19 vaccine among those working in long-term care facilities.
A new Dartmouth-led study published this month in the New England Journal of Medicine sheds light on the role U.S. health systems play concerning racial inequality in prescription pain medicine receipt.
Dr. Eugene Nelson discusses how research teams from The Dartmouth Institute for Health Policy and Clinical Practice, East Carolina University’s Brody School of Medicine, and Dartmouth-Hitchcock Health are partnering to address the negative impacts of the current pandemic as well as those that may occur in the future.
Physician-researcher Amber Barnato, MD, MPH, MS, has been named the new director of The Dartmouth Institute for Health Policy and Clinical Practice (TDI).
Congratulations to The Dartmouth Institute Class of 2021! On Friday, June 11, 2021, we will celebrate the graduates from our Master of Public Health, MS in Healthcare Research, and PhD programs. Stay tuned to this page for our livestream coverage of the 2021 Class Day event.
A team of researchers at Geisel, led by Glyn Elwyn, MD, PhD, MSc, has received a $2.1 million funding award from the Patient-Centered Outcomes Research Institute to develop a shared decision-making process to help women with breast cancer choose between surgical treatments.
A Geisel-led study reveals that there is substantial variation across different regions of the country in the intensity of fracture-associated drug use among long-term care residents, and that areas with greater use of these prescription drugs experience higher fracture rates.
New findings published by Dartmouth researchers and featured in a special issue of Health Services Research, are helping to generate new insights and knowledge about the prevalence, roles, and impact of integrated health systems.
Researchers at Dartmouth’s Geisel School of Medicine have been awarded $2.4 million in federal funding to support ongoing studies aimed at enhancing American healthcare providers’ response to the COVID-19 pandemic.
Results from a new study co-led by researchers at Dartmouth’s Geisel School of Medicine and the Department of Surgery at Kuma Hospital in Kobe, Japan, show that active surveillance can be successfully implemented as a viable treatment option for patients with low-risk thyroid cancer.
Upcoming EventsThis page may link to PDF files. Use this link to download Adobe Reader if needed.